ABSTRACT
INTRODUCTION
Liver is a complex organ that is well designed for its central role in carbohydrate, protein and fat metabolism. It is the site where waste products of metabolism are detoxified. It is responsible for synthesizing and secreting bile and synthesizing lipoproteins and plasma proteins, including clotting factors (1) . Liver is responsible for concentrating and metabolizing the majority of drugs and toxins (2) . Liver function tests are valuable in detecting impairments of liver and impending hepatitis, drug toxicity, infiltrative lesions such as tumors and certain stages of cirrhosis (3) . The determination of ALT and AST is of a real value in distinguishing hepatocellular and obstructive jaundice.
They are especially important in the early diagnosis of infective hepatitis (4) . It appeared that AST activity is more sensitive reflection of chronic hepatitis and that ALT is more readily elevated by acute hepatitis (5) . GSH plays a key role in protection against tissue damage caused by oxidative stress (6) and in regulation of the immune response (7) . The GSH is an important tool in the defense mechanism against reactive oxygen species, its depletion could be attributed to its consumption by the liberated free radicals (8) . Carbon tetrachloride when administered is distributed throughout the whole body (9) , with highest concentrations in liver, brain, kidney, muscle, fat and blood. The parent compound is eliminated primarily in exhaled air, while minimal amounts are excreted in the feces and urine (9) . CCl 4 intoxication, also, leads to hypomethylation of cellular components; in the case of RNA the outcome is thought to be inhibition of protein synthesis, in the case of phospholipids it plays a role in the inhibition of lipoprotein secretion.
None of these processes is considered the ultimate cause of CCl 4 -induced cell death; it is by cooperation that they achieve a fatal outcome, provided the toxicant acts in a high single dose, or over longer periods of time at low doses (10) . L-carnitine is 4-trimethylamino-3-hydroxybutyrate. It is synthesized chiefly in the liver and kidneys from the essential amino acid L-lysine residues in certain proteins (11) . Chronic kidney disease and some forms of liver disease may be indications for Lcarnitine supplementation. Preliminary work suggested that L-carnitine can reduce fat deposits in some fatty livers (12) . Carnitine deficiencies are occasionally associated with other diseases, such as diabetes and cirrhosis (13) . Carnitine deficiency in humans is associated with myopathy (14) and impaired fatty acid oxidation (15) . Coenzyme Q 10 (CoQ 10 ) or ubiquinone is a vitamin-like substance that is synthesized in all tissues. CoQ 10 is the coenzyme for at least three mitochondrial enzymes (complexes I, II and III). The electron and proton transfer functions of the quinine ring are of fundamental importance to all life forms (16) . The role of ubiquinone (CoQ 10 ) as a component of the mitochondrial respiratory chain, and an intracellular antioxidant has gained attention. In vitro study demonstrated that CoQ 10 protected membrane phospholipids and serum LDL from lipid peroxidative stress (17) . In vivo study reported that CoQ 10 reduced myocardial ischemia and reperfusion injury induced by oxidative stress through suppression of the formation of reactive oxygen species (18) .
MATERIALS & METHODS

Experimental animals
Eighty male albino rats of 150-200g body weight (El-Nasr Pharmaceutical Company,Cairo, Egypt) were recruited for the present study. Rats were housed in metabolic cages at constant experimental condition of temperature of 25°C with 12 hours light/dark cycle. Animals were fed on rodent chow diet (ADWIC Co., Cairo, Egypt) and allowed free access of drinking water.
Induction of Liver cirrhosis
Liver Livers were removed from sacrificed rats. Briefly the liver tissues were homogenized in hexane/propanol (3:2 v/v) and centrifuged. The extract was collected and washed with aqueous sodium sulfate. Supernatant was evaporated and the precipitate was weighed, dissolved in 10 ml hexane and stored at -20°C prior to analysis (22) . Lipid peroxides level (MDA), reduced glutathione, total LDH activities, total protein levels was determined and LDH isoenzymes were separated by gel electrophoresis.
Lipid peroxides level was determined according to the method of Ohkawa et al. (23) , reduced glutathione content was determined according to the method described by Moron et al. (24) . Serum and hepatic total protein levels were determined according to the method described by Bradford (25) . Amino transferases (ALT & AST) were determined according to the method described by Reitman and Frankel (26) , total LDH activities was determined according to the method described by Babson and Babson (27) and separation of LDH isoenzymes by gel electrophoresis by the method of Dietz and Lubrano (28) .
Statistical analysis
Data were expressed as mean ± SE. Results were analyzed by studentt-test using InStat-3 program. P<0.05 was considered statistically significant. ) . Also, it showed decreased serum level of total protein confirming other result (43) and hepatic reduced glutathione a result is in agreement with that of Allis et al. (38) . The earliest change in CCl 4 hepatotoxicity is the blockage of lipoprotein secretion and the accumulation of lipids in the liver (44) . In the present investigation, CCl 4 injection produced a significant increase in serum total LDH activity finding confirming other studies (39, 41) and caused a significant increase in serum levels of all LDH isoenzymes. Also, there was a significant increase in hepatic LDH activity after injection of CCl 4 , in accordance with the result of Seeto et al. (45) , this is due to the increasing in LDH leakage from rat hepatocytes that may be attributed to CCl 4 -induced dehalogenation in the liver endoplasmic reticulum. This process leads to trichlormethyl radical (CCl 3
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• ) formation and initiation of lipid peroxidation (46) . In the present study, levels of MDA were shown to be significantly decreased on injection of L-carnitine in CCl 4 induced hepatotoxicity. Lcarnitine administration stimulates β-oxidation of fatty acids and reduces the esterification of triacylglycerol (47) and its level in the liver tissue was found to be low in the case of cirrhosis (48) . (42) . Administration of L-carnitine or/and coenzyme Q 10 (prior to CCl 4 injection) significantly decreased hepatic and serum total LDH activity compared to CCl 4 control group in harmony with other studies (39, 42) . LDH-1 isoenzyme is maximally active at low concentration of pyruvate and inhibited by excess pyruvate, while LDH-5 isoenzyme maintains its activity at high pyruvate concentration (55) . The electrophoretic separation pattern of serum lactate dehydrogenase isoenzymes in normal and cirrhotic groups showed that CCl 4 injection resulted in a significant increase in serum levels of all LDH isoenzymes. The treatment with Lcarnitine resulted in a significant increase in isoenzyme 2, 3 and 4; and a significant decrease in isoenzyme 1 and 5. Treatment with coenzyme Q 10 resulted in a significant decrease in all isoenzymes.
Treatment with a combination of L-carnitine and coenzyme Q 10 resulted in a significant increase in isoenzyme 4 and a significant decrease in isoenzyme 1, 2, 3 and 5.
Conclusion: From the previous results, it could be concluded that Lcarnitine and coenzyme Q 10 have a pronounced prophylactic effect against liver damage induced by halogenated alkanes and the combination of Lcarnitine and CoQ 10 . 
